Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1994 1
1995 2
1997 1
1998 1
1999 1
2000 3
2001 2
2002 3
2003 4
2004 1
2005 1
2006 1
2010 1
2011 2
2012 2
2013 5
2014 1
2015 3
2016 2
2017 5
2018 2
2019 2
2020 5
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
No TWEAK for COPD.
Lazaar AL, Miller BE, Francombe G, Duvoix A, Natanek SA, Polkey MI. Lazaar AL, et al. Eur Respir J. 2013 Oct;42(4):1142-4. doi: 10.1183/09031936.00035413. Eur Respir J. 2013. PMID: 24081764 Free article. No abstract available.
Elevated airway purines in COPD.
Esther CR Jr, Lazaar AL, Bordonali E, Qaqish B, Boucher RC. Esther CR Jr, et al. Among authors: lazaar al. Chest. 2011 Oct;140(4):954-960. doi: 10.1378/chest.10-2471. Epub 2011 Mar 31. Chest. 2011. PMID: 21454402 Free PMC article.
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
Stott-Miller M, Müllerová H, Miller B, Tabberer M, El Baou C, Keeley T, Martinez FJ, Han M, Dransfield M, Hansel NN, Cooper CB, Woodruff P, Ortega VE, Comellas AP, Paine Iii R, Kanner RE, Anderson W, Drummond MB, Kim V, Tal-Singer R, Lazaar AL. Stott-Miller M, et al. Among authors: lazaar al. Int J Chron Obstruct Pulmon Dis. 2020 Oct 13;15:2467-2476. doi: 10.2147/COPD.S267002. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33116463 Free PMC article.
Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD.
Lazaar AL, Miller BE, Tabberer M, Yonchuk J, Leidy N, Ambery C, Bloomer J, Watz H, Tal-Singer R. Lazaar AL, et al. Eur Respir J. 2018 Oct 4;52(4):1801020. doi: 10.1183/13993003.01020-2018. Print 2018 Oct. Eur Respir J. 2018. PMID: 30139779 Free article. Clinical Trial. No abstract available.
52 results